Cargando…

GABA(A) receptor autoimmunity: A multicenter experience

OBJECTIVE: We sought to validate methods for detection and confirmation of GABA(A) receptor (R)-IgG and clinically characterize seropositive cases. METHODS: Archived serum and CSF specimens (185 total) suspected to harbor GABA(A)R-IgG were evaluated by indirect immunofluorescence assay (IFA). Twenty...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Connor, Kevin, Waters, Patrick, Komorowski, Lars, Zekeridou, Anastasia, Guo, Chu-Yueh, Mgbachi, Victor C., Probst, Christian, Mindorf, Swantje, Teegen, Bianca, Gelfand, Jeffrey M., Geschwind, Michael D., Lennon, Vanda, Pittock, Sean J., McKeon, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501640/ https://www.ncbi.nlm.nih.gov/pubmed/31119187 http://dx.doi.org/10.1212/NXI.0000000000000552

Ejemplares similares

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association
por: Alfugham, Nora, et al.
Publicado: (2017)

Aquaporin-4 autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2015)

Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates
por: Dubey, Divyanshu, et al.
Publicado: (2020)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Neurochondrin neurological autoimmunity
por: Shelly, Shahar, et al.
Publicado: (2019)

A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG
por: Alfugham, Nora, et al.
Publicado: (2016)

Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Case Report: Innate Immune System Challenge Unleashes Paraneoplastic Neurological Autoimmunity
por: Zhu, Mingqin, et al.
Publicado: (2020)

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
por: Honorat, Josephe A., et al.
Publicado: (2019)

Autoimmune Encephalitis Criteria in Clinical Practice
por: Orozco, Emma, et al.
Publicado: (2023)

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity
por: Vorasoot, Nisa, et al.
Publicado: (2023)

Autoimmune septin-5 cerebellar ataxia
por: Honorat, Josephe A., et al.
Publicado: (2018)

Elevated LGI1‐IgG CSF index predicts worse neurological outcome
por: Gadoth, Avi, et al.
Publicado: (2018)

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians
por: Majed, Masoud, et al.
Publicado: (2016)

Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021)

Autoimmune Encephalitis Misdiagnosis in Adults
por: Flanagan, Eoin P., et al.
Publicado: (2022)

Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers
por: McKeon, Andrew, et al.
Publicado: (2020)

Paraneoplastic neuronal intermediate filament autoimmunity
por: Basal, Eati, et al.
Publicado: (2018)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation
por: Miske, Ramona, et al.
Publicado: (2016)

Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy
por: Apiwattanakul, Metha, et al.
Publicado: (2016)

Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
por: McCombe, Jennifer A., et al.
Publicado: (2023)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration
por: Miske, Ramona, et al.
Publicado: (2016)

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
por: McKeon, Andrew, et al.
Publicado: (2023)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia
por: Miske, Ramona, et al.
Publicado: (2023)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Development of a Recombinant Cell-Based Indirect Immunofluorescence Assay for the Determination of Autoantibodies against Soluble Liver Antigen in Autoimmune Hepatitis
por: Radzimski, Christiane, et al.
Publicado: (2013)

Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021)

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders
por: Hinson, Shannon R., et al.
Publicado: (2018)

Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria
por: Chia, Nicholas H., et al.
Publicado: (2023)

Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes
por: Shah, Shailee, et al.
Publicado: (2021)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
por: Lang, Bethan, et al.
Publicado: (2017)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome
por: Rezk, Mohamed, et al.
Publicado: (2023)

Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018)

Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects
por: Roeben, Benjamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2avt7c4mqmblgqj10qq5spgsdp